C.Albicans Met6

INTRODUCTION
Candida albicans is a diploid fungus, which grows both as yeast and filamentous cells and a contributory agent of opportunistic oral and genital infections in humans, and candidal onychomycosis (an infection of the nail plate). Systemic fungal infections (fungemias) including those by C. albicans are regarded as key causes of morbidity and mortality in immunocompromised patients (e.g., AIDS, cancer chemotherapy, organ or bone marrow transplantation). C. albicans biofilms may develop on the surface of implantable medical devices. C. albicans is commensal and a constituent of the normal gut flora containing microorganisms which live in the human mouth and gastrointestinal tract. Overgrowth of the fungus leads to in candidiasis (candidosis). Candidiasis is frequently detected in immunocompromised persons, including HIV-infected patients. To infect host tissue, the habitual unicellular yeast-like form of C. albicans reacts to environmental signals and changes into an invasive, multicellular filamentous form, a phenomenon which is known as dimorphism.

DESCRIPTION
Recombinant Candida Albicans Met6 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 87,275 Dalton.
C.Albicans Met6 is expressed with a 10xHis tag at N-terminus and purified by proprietary chromatographic techniques.

https://www.prospecbio.com/calbicans_met6